Table 2

Absolute and relative changes in patients’ characteristics at 6-month follow-up according to the vital status of the patient

6-month changes inSurvivors without transplant n = 74Death or transplant n = 21P-value
BNP (pg/mL)−118.1 ± 232.9+231.2 ± 485.70.004
3D RV EF (%)+5.6 ± 9.4−3.8 ± 10.40.0004
Relative change (%E1)+20.8 ± 37.9−7.5 ± 28.00.001
3D RV EDV (mL)−3.4 ± 35.0+23.7 ± 46.10.02
Relative change (%E1)+6.6 ± 37.6+29.2 ± 51.00.03
Global RV area strain (%)−3.8 ± 6.7+3.6 ± 6.70.0001
Relative change (%E1)+10.4 ± 35.6−45.1 ± 75.90.0001
Global RV circumferential strain (%)−1.9 ± 4.3+2.4 ± 4.50.0005
Relative change (%E1)+23.4 ± 47.6−15.6 ± 32.90.0006
Global RV longitudinal strain (%)−2.2 ± 4.5+1.4 ± 3.60.001
Relative change (%E1)+61.5 ± 174.7−15.0 ± 50.60.001
TAPSE (mm)+0.0 ± 6.9−0.2 ± 6.30.52
Relative change (%E1)+5.7 ± 29.6−6.2 ± 26.50.11
S’ (cm/s)+0.7 ± 2.0−0.3 ± 2.50.08
Relative change (%E1)+8.0 ± 17.8−0.01 ± 26.10.14
RA area (cm2)−1.4 ± 6.7+3.4 ± 9.40.05
Relative change (%E1)−2.0 ± 23.6+9.0 ± 19.20.07
LV EF (%)−0.62 ± 17.3−0.26 ± 23.80.94
Relative change (%E1)−2.8 ± 20.7−4 ± 27.50.88
LV EDD (mm)+0.2 ± 1.3−0.2 ± 1.50.26
Relative change (%E1)+0.5 ± 2.9−0.4 ± 3.40.25
6-month changes inSurvivors without transplant n = 74Death or transplant n = 21P-value
BNP (pg/mL)−118.1 ± 232.9+231.2 ± 485.70.004
3D RV EF (%)+5.6 ± 9.4−3.8 ± 10.40.0004
Relative change (%E1)+20.8 ± 37.9−7.5 ± 28.00.001
3D RV EDV (mL)−3.4 ± 35.0+23.7 ± 46.10.02
Relative change (%E1)+6.6 ± 37.6+29.2 ± 51.00.03
Global RV area strain (%)−3.8 ± 6.7+3.6 ± 6.70.0001
Relative change (%E1)+10.4 ± 35.6−45.1 ± 75.90.0001
Global RV circumferential strain (%)−1.9 ± 4.3+2.4 ± 4.50.0005
Relative change (%E1)+23.4 ± 47.6−15.6 ± 32.90.0006
Global RV longitudinal strain (%)−2.2 ± 4.5+1.4 ± 3.60.001
Relative change (%E1)+61.5 ± 174.7−15.0 ± 50.60.001
TAPSE (mm)+0.0 ± 6.9−0.2 ± 6.30.52
Relative change (%E1)+5.7 ± 29.6−6.2 ± 26.50.11
S’ (cm/s)+0.7 ± 2.0−0.3 ± 2.50.08
Relative change (%E1)+8.0 ± 17.8−0.01 ± 26.10.14
RA area (cm2)−1.4 ± 6.7+3.4 ± 9.40.05
Relative change (%E1)−2.0 ± 23.6+9.0 ± 19.20.07
LV EF (%)−0.62 ± 17.3−0.26 ± 23.80.94
Relative change (%E1)−2.8 ± 20.7−4 ± 27.50.88
LV EDD (mm)+0.2 ± 1.3−0.2 ± 1.50.26
Relative change (%E1)+0.5 ± 2.9−0.4 ± 3.40.25

BNP, brain natriuretic peptide; EDV, end-diastolic volume; EF, ejection fraction; LV, left ventricular; RA, right atrial; RV, right ventricular.

P-value was obtained using Student’s t-test.

Table 2

Absolute and relative changes in patients’ characteristics at 6-month follow-up according to the vital status of the patient

6-month changes inSurvivors without transplant n = 74Death or transplant n = 21P-value
BNP (pg/mL)−118.1 ± 232.9+231.2 ± 485.70.004
3D RV EF (%)+5.6 ± 9.4−3.8 ± 10.40.0004
Relative change (%E1)+20.8 ± 37.9−7.5 ± 28.00.001
3D RV EDV (mL)−3.4 ± 35.0+23.7 ± 46.10.02
Relative change (%E1)+6.6 ± 37.6+29.2 ± 51.00.03
Global RV area strain (%)−3.8 ± 6.7+3.6 ± 6.70.0001
Relative change (%E1)+10.4 ± 35.6−45.1 ± 75.90.0001
Global RV circumferential strain (%)−1.9 ± 4.3+2.4 ± 4.50.0005
Relative change (%E1)+23.4 ± 47.6−15.6 ± 32.90.0006
Global RV longitudinal strain (%)−2.2 ± 4.5+1.4 ± 3.60.001
Relative change (%E1)+61.5 ± 174.7−15.0 ± 50.60.001
TAPSE (mm)+0.0 ± 6.9−0.2 ± 6.30.52
Relative change (%E1)+5.7 ± 29.6−6.2 ± 26.50.11
S’ (cm/s)+0.7 ± 2.0−0.3 ± 2.50.08
Relative change (%E1)+8.0 ± 17.8−0.01 ± 26.10.14
RA area (cm2)−1.4 ± 6.7+3.4 ± 9.40.05
Relative change (%E1)−2.0 ± 23.6+9.0 ± 19.20.07
LV EF (%)−0.62 ± 17.3−0.26 ± 23.80.94
Relative change (%E1)−2.8 ± 20.7−4 ± 27.50.88
LV EDD (mm)+0.2 ± 1.3−0.2 ± 1.50.26
Relative change (%E1)+0.5 ± 2.9−0.4 ± 3.40.25
6-month changes inSurvivors without transplant n = 74Death or transplant n = 21P-value
BNP (pg/mL)−118.1 ± 232.9+231.2 ± 485.70.004
3D RV EF (%)+5.6 ± 9.4−3.8 ± 10.40.0004
Relative change (%E1)+20.8 ± 37.9−7.5 ± 28.00.001
3D RV EDV (mL)−3.4 ± 35.0+23.7 ± 46.10.02
Relative change (%E1)+6.6 ± 37.6+29.2 ± 51.00.03
Global RV area strain (%)−3.8 ± 6.7+3.6 ± 6.70.0001
Relative change (%E1)+10.4 ± 35.6−45.1 ± 75.90.0001
Global RV circumferential strain (%)−1.9 ± 4.3+2.4 ± 4.50.0005
Relative change (%E1)+23.4 ± 47.6−15.6 ± 32.90.0006
Global RV longitudinal strain (%)−2.2 ± 4.5+1.4 ± 3.60.001
Relative change (%E1)+61.5 ± 174.7−15.0 ± 50.60.001
TAPSE (mm)+0.0 ± 6.9−0.2 ± 6.30.52
Relative change (%E1)+5.7 ± 29.6−6.2 ± 26.50.11
S’ (cm/s)+0.7 ± 2.0−0.3 ± 2.50.08
Relative change (%E1)+8.0 ± 17.8−0.01 ± 26.10.14
RA area (cm2)−1.4 ± 6.7+3.4 ± 9.40.05
Relative change (%E1)−2.0 ± 23.6+9.0 ± 19.20.07
LV EF (%)−0.62 ± 17.3−0.26 ± 23.80.94
Relative change (%E1)−2.8 ± 20.7−4 ± 27.50.88
LV EDD (mm)+0.2 ± 1.3−0.2 ± 1.50.26
Relative change (%E1)+0.5 ± 2.9−0.4 ± 3.40.25

BNP, brain natriuretic peptide; EDV, end-diastolic volume; EF, ejection fraction; LV, left ventricular; RA, right atrial; RV, right ventricular.

P-value was obtained using Student’s t-test.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close